What should be done if a patient accidentally takes two doses of Eliquis (apixaban) in the morning instead of the usual twice‑daily schedule?

Management of Accidental Double-Dose Eliquis (Apixaban)

If a patient accidentally takes two doses of Eliquis in the morning instead of the usual twice-daily schedule, skip the evening dose that same day and resume the normal twice-daily schedule the following morning.

Immediate Management

The FDA label explicitly addresses missed doses but not double doses 1. However, the pharmacokinetic profile of apixaban provides clear guidance for this scenario:

• Do NOT take the evening dose on the day of the double-dose error
• Resume normal BID dosing the next morning (approximately 24 hours after the double dose)
• Monitor for bleeding signs (unusual bruising, blood in urine/stool, prolonged bleeding from cuts, severe headache)
• No reversal agents or activated charcoal needed unless the patient took a massive overdose (>10 tablets)

Rationale Based on Apixaban Pharmacokinetics

Apixaban has a half-life of approximately 12 hours 2, 3. Taking two doses in the morning (e.g., 10 mg instead of 5 mg) creates a temporary overdose situation, but the drug will be substantially eliminated within 24 hours. Key pharmacokinetic considerations:

• Peak concentration occurs 3-4 hours after ingestion 2
• Steady-state is reached by day 3 of regular dosing 3
• The drug follows first-order elimination kinetics 4
• A single double-dose will not cause sustained supratherapeutic levels if the next dose is appropriately delayed

Bleeding Risk Assessment

Evidence from overdose cases demonstrates that even massive apixaban overdoses (60-70 tablets, achieving concentrations of 2,200-4,000 ng/mL versus therapeutic range of 91-321 ng/mL) did not result in bleeding complications 4, 5, 6. A double-dose represents only 2x the intended dose, placing the patient at minimal bleeding risk.

However, monitor for:

• Visible bleeding (gums, nose, gastrointestinal, urinary)
• Occult bleeding signs (unexplained anemia, hemodynamic instability)
• Neurological symptoms suggesting intracranial hemorrhage

When to Consider Activated Charcoal

Activated charcoal is only indicated if:

• The double-dose was taken within 2-4 hours of presentation 1
• The patient took a massive overdose (>10 tablets)
• The patient has additional bleeding risk factors (recent surgery, concurrent antiplatelet therapy, severe renal impairment)

The FDA label notes that activated charcoal given 2 hours after a 20 mg dose reduced apixaban exposure by 50% 1. Beyond 4 hours, charcoal efficacy diminishes significantly.

Common Pitfalls to Avoid

1. Do NOT double the next dose to "catch up" - this is explicitly contraindicated 1
2. Do NOT give the evening dose on the same day as the double-dose error
3. Do NOT routinely use reversal agents (andexanet alfa) for simple double-dosing - these are reserved for life-threatening bleeding 7
4. Do NOT panic - the therapeutic window for apixaban is relatively wide 5

Special Populations Requiring Extra Caution

Patients at higher bleeding risk who accidentally double-dose require closer monitoring:

• Age ≥80 years 8
• Body weight ≤60 kg 8
• Creatinine clearance 15-30 mL/min 1
• Concurrent antiplatelet therapy 8
• Recent surgery or trauma [@1-6@]

For these patients, consider:

• Direct observation for 12-24 hours
• Baseline hemoglobin/hematocrit
• Stool guaiac testing if gastrointestinal symptoms develop

Documentation and Patient Education

Document the medication error and counsel the patient on:

• Using pill organizers to prevent future errors
• The importance of not doubling doses to compensate for missed doses
• When to seek emergency care (severe bleeding, neurological symptoms)
• The correct twice-daily dosing schedule (approximately 12 hours apart)